Clinical Trials Browser

Nasopharyngeal Carcinoma × camrelizumab × 30 days × Clear all

NCT05524168 2026-05-07

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

Nasopharyngeal Carcinoma